Sponsor Dossier
Wockhardt Bio
Sponsor Dossier for Wockhardt Bio. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AMIKACIN
- Brand: AMIWOK
- Brand: APOMORPHINE
- Brand: APOWOK
- Brand: DAPTOMYCIN
- Brand: DOCETAXEL
- Brand: ICATIBANT
- Brand: IRINOTECAN
- Device (sponsor): Hypodermic needle, single-use, sterile
- Device (sponsor): Sentinel lymph node dye
- Device (sponsor): Perioperative methylene blue stain
- Device (sponsor): Disinfectant, <specify>
- Device (sponsor): Disinfectant, <specify>
- Device (sponsor): Disinfectant, <specify>
- Device (sponsor): Nasal irrigation applicator
- Device (sponsor): Disinfectant, <specify>
- Device (sponsor): Disinfectant, <specify>
About
Wockhardt Bio is an Australian Private Company with ABN 91607752090, registered in New South Wales. The entity is active and registered for GST.
Portfolio
Wockhardt Bio has 15 brands on the ARTG, of which 10 are indexable and 10 carry a Product Information document. 0 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include AMIKACIN, AMIWOK, APOMORPHINE, APOWOK, DAPTOMYCIN, DOCETAXEL, ICATIBANT, IRINOTECAN, METARAMINOL, OXALIPLATIN, OXYCODONE, SODIUM.
Therapeutic focus
— Infectious Disease: 5 brands — Neurology: 4 brands — Oncology: 3 brands — Rare Disease: 1 brand — Cardiology: 1 brand — Pain Management: 1 brand